BioSpace News Archive

NorthStar Medical Technologies, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, today announced that it will participate in the upcoming Emerging Medtech Summit 2020 conference, being held February 18 ‒ 20, 2020, in Dana Point, Ca.

Vallon Pharmaceuticals Inc., a specialty pharmaceutical company focused on the development of novel drugs for CNS disorders, today announced the presentation of positive data from a pilot study assessing human abuse liability for its investigational Abuse Deterrent Amphetamine Immediate Release (ADAIR)

Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy.

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and full year 2019 financial results on Thursday, February 6, 2020 after the close of financial markets.

Rite Aid Corporation announced the early results of its previously announced offer to exchange up to $600 million aggregate principal amount of its outstanding 6.125% Senior Notes due 2023 for newly issued 7.500% Senior Secured Notes due 2025, upon the terms and subject to the conditions set forth in the offering memorandum dated January 6, 2020.

Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareholders

CV Sciences, Inc, a preeminent supplier and manufacturer of hemp cannabidiol products through its brand PlusCBD Oil™, is the first-ever CBD sponsor of the Farmers Insurance Open.

Rafarma Pharmaceuticals, Inc. “OTC:” is happy to announce the execution of an exclusive joint venture agreement with MTP MATERIAL CO. LTD..

DoctorLogic, the creators of the all-in-one Website Marketing Platform exclusively for healthcare providers, announced it has completed a $7 million Series A round of financing.

LSNE Contract Manufacturing (LSNE), a privately held contract development and manufacturing organization, is pleased to announce a successful Pre-Approval Inspection (PAI) performed by the US Food and Drug Administration (FDA) at its aseptic fill finish facility in León, Spain.